Steven L. Soignet
- Molecular Biology top 2%
- Hematology top 0.5%
- Oncology top 5%
- Biochemistry top 0.5%
- Immunology top 10%
- Co-authors
- Raymond P. WarrellDavid A. ScheinbergElizabeth CallejaP. MaslakPier Paolo PandolfiZhugang WangJanice GabriloveA DeBlasio
- Topics
- Retinoids in leukemia and cellular processes (15 papers)Acute Myeloid Leukemia Research (13 papers)Antioxidant Activity and Oxidative Stress (8 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Steven L. Soignet
29 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Molecular Biology 3.1k
- Hematology 1.8k
- Oncology 821
- Biochemistry 567
- Immunology 377
Countries citing papers authored by Steven L. Soignet
This map shows the geographic impact of Steven L. Soignet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven L. Soignet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven L. Soignet more than expected).
Fields of papers citing papers by Steven L. Soignet
This network shows the impact of papers produced by Steven L. Soignet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven L. Soignet. The network helps show where Steven L. Soignet may publish in the future.
Co-authorship network of co-authors of Steven L. Soignet
This figure shows the co-authorship network connecting the top 25 collaborators of Steven L. Soignet. A scholar is included among the top collaborators of Steven L. Soignet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven L. Soignet. Steven L. Soignet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 33 | |
| 3 | 85 | |
| 4 | 3 | |
| 5 | 12 | |
| 6 | 173 | |
| 7 | 15 | |
| 8 | 36 | |
| 9 | 49 | |
| 10 | Phase I Trial of the Proteasome Inhibitor PS-341 in Patients With Refractory Hematologic Malignanciesbreakdown → | 586 |
| 11 | A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies. | 372 |
| 12 | 3 | |
| 13 | A phase I and pharmacological study of the farnesyl protein transferase inhibitor L-778,123 in patients with solid malignancies. | 65 |
| 14 | 2 | |
| 15 | 24 | |
| 16 | Initial clinical trial of a high-affinity retinoic acid receptor ligand (LGD1550). | 14 |
| 17 | 4 | |
| 18 | 38 | |
| 19 | Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxidebreakdown → | 1013 |
| 20 | 55 |
About Steven L. Soignet
Steven L. Soignet is a scholar working on Hematology, Biochemistry and Ophthalmology, having authored 29 papers that have together received 4.0k indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (15 papers), Acute Myeloid Leukemia Research (13 papers) and Antioxidant Activity and Oxidative Stress (8 papers). The work is most often cited by research in Hematology (1.8k citations), Biochemistry (567 citations) and Molecular Biology (3.1k citations). Steven L. Soignet has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Raymond P. Warrell, David A. Scheinberg, Elizabeth Calleja, P. Maslak, Pier Paolo Pandolfi, Zhugang Wang, Janice Gabrilove, A DeBlasio, Suresh C. Jhanwar and Julian Adams. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.